Berotralstat dihydrochloride (BCX7353 dihydrochloride) is an orally active plasma kallikrein inhibitor. Berotralstat can reduce brain edema and is being studied for glioblastoma and hereditary angioedema[1][2].
Molecular Weight:
635.48
Purity:
98.67
CAS Number:
[1809010-52-3]
Formula:
C30H28Cl2F4N6O
Target:
Kallikrein
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted